High-cost drugs. Where's the ROI?
Burns, J.
Managed Care 23(12): 20-23
2014
ISSN/ISBN: 1062-3388 PMID: 25939176 Document Number: 673847
Document emailed within 1 workday
Related Documents
Dana, W.J.; McWhinney, B. 1994: Managing high cost and biotech drugs: two institutions' perspectives Hospital Formulary 29(9): 638-645Schulman, K.A.; Kinosian, B.; Jacobson, T.A.; Glick, H.; Willian, M.K.; Koffer, H.; Eisenberg, J.M. 1990: Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management JAMA 264(23): 3025-3033
Tremblay, J. 1980: Prescription drugs and the aged: cost-free and cost-containment measures L'Union Medicale du Canada 109(3): 414-420
Moriya, A.; Usami, E.; Hirose, T.; Takenaka, S.; Asano, H.; Okada, K.; Adachi, S.; Yoshimura, T. 2019: Examination of Actual Medical Material Cost and Cost Reduction Related to Exposure Prevention in the Preparation of Anticancer Drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(8): 1281-1286
1979: Technical discussions at the 20th Panamerican Health Conference. Repercussions of the cost of drugs on the cost of health: national and international problems Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 87(6): 471-493
Evens, R.G. 1984: Radiology 1984. a conflict of high technology and high cost Journal of the Canadian Association of Radiologists 35(4): 332-337
Salines, G. 1991: Consumption of tobacco, alcohol, psychotropic drugs and illegal drugs in high school students of the department in the Upper Pyrenees Revue d'Epidemiologie et de Sante Publique 39(2): 149-155
Gyarmathy, V.Anna.; Neaigus, A.; Li, N.; Ujhelyi, E.; Caplinskiene, I.; Caplinskas, S.; Latkin, C.A. 2010: Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania European Addiction Research 16(4): 220-228
Worth, T. 2015: The rising cost of generic drugs Medical Economics 92(5): 36-39
Huff, C. 2018: MS Drugs: Expensive, Often Lifelong, and not Cost Effective Managed Care 27(10): 30-34
Fulda, T.K.; Dickens, P.F. 1979: Controlling the cost of drugs: the Canadian experience Health Care Financing Review 1(2): 55-64
Szuba, T. 1987: Cost evaluation of branded and generic drugs Materia Medica Polona. Polish Journal of Medicine and Pharmacy 19(2): 137-142
Kumar, S. 2001: Indian company offers low cost AIDS drugs Lancet 357(9256): 616
Vasil'eva, I.S.; Muzyra, I.A.; Lysak, L.S.; Tikhonova, L.A.; Efron, I.I. 1982: Cost of drugs used to treat patients in tuberculosis hospitals Problemy Tuberkuleza 10: 14-17
Pollock, K.; Grime, J. 2000: Patients' views on cost effectiveness of drugs are important Bmj 321(7271): 1292
McGettrick, S.; Rodgers, J. 1996: Cost of administering controlled drugs in a hospice ward Health Bulletin 54(6): 441-442
MacDonald, R. 2000: Cost effectiveness of multiple sclerosis drugs remains unknown Bmj 321(7258): 399
Lopert, R.; Lang, D.L.; Hill, S.R.; Henry, D.A. 2002: Differential pricing of drugs: a role for cost-effectiveness analysis? Lancet 359(9323): 2105-2107
McManus, V. 2003: The high cost of low morale Dentistry Today 22(7): 68-71
Hawkes, N. 2014: NICE uses wrong comparator to assess cost effectiveness of new drugs, report says Bmj 348: G2134